Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 960-966

  Fang, Mingli ^a   Wang, Hua ^a   Tang, Tongyu ^b   Zhao, Peiyan ^a   Du, Junyang ^a   Guo, Sheng ^a   Wei, Hongfei ^a   Xu, Haifei ^a   Wan, Min ^a   Wei, Xuefeng ^c   Yu, Yongli ^a   Wang, Liying ^a  

^a Basic Medical College   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c Inner Mongolia Jinyu Group Baoling Bio pharmaceutical Corporation   (China)

Author keywords

Foot and mouth disease virus (FMDV); Recombinant epitope vaccine; Serotype Asia 1; VP1 capsid protein

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY; PROTEIN VP1; RECOMBINANT PROTEIN; CAPSID PROTEIN; RECOMBINANT VACCINE; SUBUNIT VACCINE; VIRUS ANTIBODY; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BOVINE; CELLULAR IMMUNITY; CONTROLLED STUDY; DUNKIN HARTLEY GUINEA PIG; ESCHERICHIA COLI; FEMALE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA 1; IMMUNIZATION; INOCULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; FOOT-AND-MOUTH DISEASE; GENETICS; GUINEA PIG; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CATTLE; CELLS, CULTURED; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; TH1 CELLS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84979180120     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.08.017     Document Type: Article

References (45)

1. [1] Abdul-Hamid, H.F., Hussein, N.M., Wadsworth, J., et al. Phylogeography of foot and mouth disease virus types O and A in Malaysia and surrounding countries. Infect. Genet. Evol. 11 (2011), 320–328.
2. [2] Bhattacharya, S., Banerjee, R., Ghosh, R., et al. Studies of the outbreaks of foot and mouth disease in West Bengal, India, between 1985 and 2002. Rev. Sci. Tech. 24 (2005), 945–952.
3. [3] Bittle, J.L., Houghten, R.A., Alexander, H., et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982), 30–33.
4. [4] Chung, W.B., Liao, P.C., Chen, S.P., et al. Optimization of foot-and-mouth disease vaccination protocols by surveillance of neutralization antibodies. Vaccine 20 (2002), 2665–2670.
5. [5] Collen, T., Dimarchi, R., Doel, T.R., A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J. Immunol. 146 (1991), 749–755.
6. [6] DiMarchi, R., Brooke, G., Gale, C., et al. Protection of cattle against foot-and-mouth disease virus by a synthetic peptide. Science 232 (1986), 639–641.
7. [7] Domingo, E., Baranowski, E., Escarmís, C., et al. Foot-and-mouth disease virus. Comp. Immunol. Microbiol. Infect. Dis. 25 (2002), 297–308.
8. [8] Doel, T.R., FMD vaccines. Virus Res. 91 (2003), 81–99.
9. [9] Doel, T.R., Optimization of the immune response to foot-and-mouth disease vaccines. Vaccine 17 (1999), 1767–1771.
10. [10] Eisen, H.N., Little, J.R., Steiner, L.A., et al. Degeneracy in the secondary immune response: stimulation of antibody formation by cross-reacting antigens. Isr. J. Med. Sci. 5 (1969), 338–351.
11. [11] Doel, T.R., Gale, C., Brooke, G., DiMarchi, R., Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1. J. Gen. Virol. 69 (1988), 2403–2406.
12. [12] Fang, M.L., Li, J.L., Wang, H., et al. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus., 34, 2012, 839–847.
13. [13] Francis, M.J., Hastings, G.Z., Syred, A.D., et al. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 330 (1987), 168–170.
14. [14] Gerner, W., Hammer, S.E., Wiesmüller, K.H., et al. Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J. Virol. 83 (2009), 4039–4050.
15. [15] Gao, F.S., Feng, L., Zhang, Q., et al. Immunogenicity of two FMDV nonameric peptides encapsulated in liposomes in mice and the protective efficacy in guinea pigs. PLoS One, 8, 2013.
16. [16] Guo, H.C., Sun, S.Q., Jin, Y., et al. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet. Res. 4 (2013), 44–48.
17. [17] Jamal, S.M., Ahmed, S., Hussain, M., et al. Status of foot-and-mouth disease in Pakistan. Virology 155 (2010), 1487–1491.
18. [18] Jin, H., Kang, Y., Xiao, C., et al. DNA prime followed by protein boost enhances neutralization and Th1 type immunity against FMDV. Viral Immunol. 18 (2005), 539–548.
19. [19] Jin, H.L., Xiao, W., Xiao, C., et al. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles. Viral Immunol. 20 (2007), 429–440.
20. [20] Kleid, D.G., Yansura, D., Small, B., et al. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine., 214, 1981, 1125–1129.
21. [21] Le, V.P., Nguyen, T., Park, J.H., et al. Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam. Vet. Microbiol. 145 (2010), 220–229.
22. [22] Li, S., Gao, M., Zhang, R., et al. A mutant of infectious Asia 1 serotype foot-and-mouth disease virus with the deletion of 10-amino-acid in the 3A protein. Virus Genes 41 (2010), 406–413.
23. [23] Luis, L.R., Marvin, J.G., Foot and mouth disease virus vaccines. Vaccine 27 (2009), 90–94.
24. [24] Mackay, D.K., Forsyth, M.A., Davies, P.R., et al. Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Vet. Q. 20:Suppl. 2 (1998), S9–11.
25. [25] Mannering, S.I., Morris, J.S., Jensen, K.P., et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J. Immunol. Methods 283 (2003), 173–183.
26. [26] Marcelino, J.M., Borrego, P., Rocha, C., et al. Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy. J. Virol. 84 (2010), 12429–12436.
27. [27] McCullough, K.C., Bruckner, L., Schaffner, R., et al. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30 (1992), 99–112.
28. [28] Morgan, D.O., Moore, D.M., Protection of cattle and swineagainst foot-and-mouth disease, using biosynthetic peptide vaccines. Am. J. Vet. Res. 51 (1990), 40–45.
29. + T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection. PLoS One, 7, 2012, e44365.
30. [30] Pacheco, J.M., Brum, M.C., Moraes, M.P., et al. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337 (2005), 205–209.
31. [31] Patch, J.R., Kenney, M., Pacheco, J.M., et al. Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination. Viral Immunol. 26 (2013), 239–249.
32. [32] Rodriguez, L.L., Barrera, J., Kramer, E., et al. A synthetic peptide containing the consensus sequence of the G–H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21 (2003), 3751–3756.
33. [33] Rodriguez, L.L., Grubman, M.J., Foot and mouth disease virus vaccines. Vaccine 27:4 (2009), 90–94.
34. [34] Rothbard, J.B., Taylor, W.R., A sequence pattern common to T cell epitopes. EMBO J. 7 (1988), 93–100.
35. [35] Sobrino, F., Saiz, M., Jimenez-Clavero, M.A., et al. (Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32 (2001), 1–30.
36. [36] Shao, J.J., Wong, C.K., Lin, T., et al. A promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin. Vaccine Immunol. 18 (2011), 143–149.
37. [37] Subramaniam, S., Pattnaik, B., Sanyal, A., et al. Status of foot-and-mouth disease in India. Transbound. Emerg. Dis. 60 (2013), 197–203.
38. [38] Taboga, O., Tami, C., Carrillo, E., et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71 (1997), 2606–2614.
39. [39] Trautman, R., Bennett, C.E., Relationship between virus neutralization and serum protection bioassays for IgG and IgM antibodies to foot-and-mouth disease virus. J. Gen. Virol. 42 (1979), 457–466.
40. [40] van Lierop, M.J., van Maanen, K., Meloen, R.H., et al. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75 (1992), 406–413.
41. [41] van Lierop, M.J., Wagenaar, J.P., van Noort, J.M., et al. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J. Virol. 69 (1995), 4511–4514.
42. [42] Wang, J.L., Liu, M.Q., Han, J., et al. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide. Vet. Microbiol. 125 (2007), 224–231.
43. [43] Zhang, Z., Pan, L., Ding, Y., et al. Efficacy of synthetic peptide candidate vaccines against serotype—A foot-and-mouth disease virus in cattle. Appl. Microbiol. Biotechnol. 99 (2015), 1389–1398.
44. [44] Zhang, Z.W., Zhang, Y.G., Wang, Y.L., et al. Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1. Vet. Microbiol. 140 (2010), 25–33.
45. [45] Zamorano, P., Wigdorovitz, A., Perez-Filgueira, M., et al. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Virology 212 (1995), 614–621.